Member Info for robrob

Good to see a RNS,

Wasted opportunity again, who ever is writing these needs to think about what investors want and need from these updates:

- what’s the Moq?
- select number… just tell us an estimate is it 1 distributor or 100?
- sales figures / forecast / expected first year Rev?
- market size for the compound in Germany from their research
- what’s the sale price of items sold
- contract? Sales agreement? Exclusive or open distributors?

Don’t tell me they cannot due to competitors, this could have been a great Rns but again it filled the theme of giving the least information out!

I think like most of us, Leap is a potential exit point, there is no real line of sight to the sales, licensing, general profitability and/or how “deep” LEAP is with IMG - it’s anyone guess!!

Doggo, can you remind me when you told this board the SP would be 30p SP I think you said Easter (2021) and that you were going to eat your hat? or words along those lines. I am considering framing it.

yes it was my turn.

Glad you find it amusing.

Reefles,

I'm not sure, that would be good of course! However I'm not confident there is any meaningful rally.

*Share price November 2021 = 7.5p,

should be seen as

Share price November 2020 = 7.5p

Goonertone7, I cannot give advice, but what I said is an observation that the shareprice and MCap has been stagnant at best, or is in decline, while the rhetoric is that SEED has the bulk of its portfolio in two sectors that have grown enormously over the last 12-24 months, shareholders again have seen no return.

The structure of the positions/roles in the company hold are engineered, managed or/and created solely by the BoD and its their responsibility to keep shareholders updated, it's not my responsibility to sympathise that a CEO cannot buy shares.

Remember Ed was a NED in other organisations before and has purchased other shares in other companies that it would appear he has had involvement with. IMO it's not ?any shareholders responsibility to accept that a news black out is considered acceptable.

We have the bulk of the portfolio in one single asset, LEAP (40%?), is it acceptable to tell shareholders there might be an IPO before Xmas, but likely not, but also bear in mind it may be sold. What does that mean? Can anyone invest on the type of limited information??

Remember, this is a closed fund, it's where you would normally expect returns through higher share price and/or dividends if it were profitable. What have shareholders had in the last four years?

(from my notes, you can check yourself if you want)
Share price November 2018 = 11p
Share price November 2019 = 8.75p
Share price November 2021 = 7.5p
Share price November 2021 = 6p?

And remind me what salaries and expenses are being paid to the Directors? and what shares have been 'gifted' away?

As I said before, the track record and information flow indicates this is going to 5/6p.

GLA DYOR

It's all very unfortunate.

Realistically this fund should be flying, its two main areas being cannaboid/cbd/cannabis and online gaming, these being substantial and proven growth markets, unfortunately SEED is continuing the well below average performance trend of FFWD.

As these markets are growing considerably there is not really any excuse for SEED to not being seeing a growth in SP and MCap.

Is Ed waiting for this to go below 5.9 to prove a point to Lance?

This feels like its going to 6p, and soon,, but even 5p is on the cards in this "No news November".

Remember, we've already been told its unlikely there is any news before Xmas, so this leaves the question if there is a gradual decline of SP due to no news each week, what SP are we going to be really looking at? My reckoning is 6p a best target, but am expecting much lower.

Looking more like this is going to 6p SP this week, appears the sellers outweigh buys heavily.

News void continues….will BoD do anything to address the market sensibly with LEAP news and their progress.

I don't think that individual will be able to buy large volumes at the same price they sold at, even if they did have inside information, there isn't the liquidity in this stock for sustained buying it would seem for 7-8p. The problem is no one is buying due to no information for insiders or public

Hi Goodhand,

Why?
Andina was specified via RNS for Emmac and Ed was a Director of the business in 2020, I believe, as were commercial dealings shared via numbers of RNS while FFWD board members and management were involved in EMMAC. So it does seem that there can be a news flow to asset. Of course some discussions would and must be protected, but surely this far into the route to IPO we would be hearing more than what has been shared.

It would seem that from the lack of RNS there is no interest for acquisition. I mean, I expect most of us on this BB would be peeved if it was sold off, under value, when we were expecting a IPO. Not like we've seen that happen before!?

Totally agree with you though, it feels like "anything" could happen with LEAP.

For me, I'd prefer to know more about my investment in SEED and not have it as a gamble between IPO and Sale. The EMMAC IPO was touted as a major opportunity but then Shareholders seemed to only realised a small return compared to what the discussion board and there was no dividend for the likes of average Joe, and the SP has tanked. So if you trade SEED/FFWD, great, but not so good for the loyal shareholders?

The majority of people I spoke with were hoping/wanting/expecting a good return from EMMAC, and don't get me wrong... it was a good return for FFWD but based on the portfolio of losses it was not near the return some were hoping for and not a "great" return for a trophy in the portfolio stable.

IMO, many shareholders are looking for a 'great' return from LEAP. Ed has commented his frustrations of the market not seeing the value of SEED/FFWD investments or the cash 'shell' when we were more liquid earlier this year.

So it goes back to the question, what can the Board do differently to inform the market of their intentions and progress? Do we need to rely on the drop of a knife one day when news comes out.

There was a time when SP was sitting well ABOVE Nav and it was commented on highly. These days, it sits with the SP BELOW Nav, month after month. What can we draw from this?

This is an investment fund, so if there is no return from investment via dividends and if potential investors do not understand the time for their investment return it would make for a difficult journey, and at their expense.

Im hopeful that we seen IPO for LEAP, but as you say - anything could happen.

IMO, DYOR.

Is this not a discussion board Doggo?

Sit in the naughty corner, shame on you...

Hi ICB888,

Yes I did watch the interview.

If you consider the run up of Nuuvera that also had legal restrictions I think you will find the level of updates and pace remarkably different from the management teams.

I hope we get to the 50 MC level and beyond, I'm rooting for it also.

It's just not clear at ALL in terms of what the vehicle is, it might be an IPO or it could be a sale. The verse is beginning to getting a little weary after many months. If its a IPO what date are we working to a prospectus? If its a sale, do we have any MOUs or NDAs? The market needs to know, this is likely one of the reasons why SP is below NAV on now unfortunately an ongoing basis.

"Whats going on" is a fair question, based that Ed has told us the target is 50M MCap before year and the only way to get there it would seem is via LEAP.

Appreciate the Board have a level of discretion, but you cannot sell a business if the market does not know it is for sale, if it is for sale, then why is there no RNS. Likewise IPO information is needed if we are aiming, even for a "slim chance" (per interview) for 2021, otherwise it seems to be just air.

I must have missed the TR1

I did see

“ SEED Innovations Limited, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health, and wellness space, announces that Rhonda Abony no longer has a notifiable interest in the Company.”

And that does not say 0%

It would have been helpful for the RNS to say 0% as less than 3% is still a lot of stock!!! Just look at how £500 affects Yooma if you catch my drift

No problem Mat

I was replying to another BB member anyway

In my opinion it’s not a good update to vague but each to our own!

Mat

Can you tell me the month Leap will IPO? I would watch the interview again as it says “in” 2022.

Makes it hard to make decisions to buy or sell on the vagueness, I’m sure you will agree

It was an interesting overview, I mirror your points :

- How time has slipped from IPO 2021, to aiming for IPO 2021, to slim chance, to early 2022, now seen as in 2022.
- Why, the focus on "multipliers", this appears to be more aligned for exits rather than IPO

Overall a good investor piece, but not enough detailing for my liking.

I'd also comment that while Rhonda is below 3%, to me that simply means there is less reporting required now, as it is not seen as a significant (Lornes gifted) investor. To this end, how do we know that the "seller has left", there were plenty of block sells in recent days still and there is no public investor information available that they have sold to 0%? Unless I missed this.

It would seem and taking from Eds words that Rhonda wanted the 'cash' so reading between the lines, that the remaining shares will be sold.

Perhaps the 7p SP is the broker sell point and at 6p the balance cannot be sold and there is outstanding instruction.

It will be interesting to see what block sells are displayed in the coming days , has the 50k seller gone or paused?

I'm hopeful that what has been given to shareholders was not spin, but I feel the share price is depressed and will continue to be so until the board give clearer liquidity information, my take away was :

There is a IPO for LEAP and it will happen at some point in 2022. Turning to retail investor bias, it's not helpful for retail investors who have been waiting for this already for X amount of months and told prepare to wait for up to another 14 months from here for a IPO.

To that end it was a disappointing update and the possibility of raising the MCap to 50M before calendar year end seems to be very difficult and out of reach. I don't understand if there is ANY plan for the Bod to achieve the financial target they set themselves for 2021 and set investor expectations on.

Are we too trundle at this dire pace for upto the next 14 months?

After speaking to many people and investors there is a clear instruction process to improving shareholder relations and increasing the share price (SP). Please pass to ED...anyone...?

1. Tell the market the month you intend to IPO LEAP.
2. Read 1. and complete.

The current SP is a reflection that NO ONE believes ED has a workable plan for LEAP.

Exactly, when will SEED BOD give its retail shareholders some FIRM information rather than the continued vague information that they are "looking" , hoping, aiming for an IPO, or is it an asset sale release, ED? Anyone?

Shareholders are getting impatient, and rightly so, there needs to be more detail and less gloss, 6p is looming, 5p is a distinct possibility in this information void.

LOL, on the packet it says

UK Responsible Person :
MediaMap Ltd
2 The Dirft....

LOL, perhaps it should read Irresponsible person!!!

I ordered new LFT, they arrived today from Medimap ltd as the distributor? and ACON Biotech as manufacturer?

Medimap looks like a really classy operation. You can see their un-secure non GDPR compliant website here at http://medimap.co.uk/

The mind boggles when you see companies like this involved with national safeguarding of our health. Hopefully ODX will get their opportunity soon.